ScripSanofi Gets IP From MSKCC, Eureka Applicable In Multiple Myeloma Therapy Sanofi signed an agreement on 6 July to acquire intellectual property covering non-chimeric antigen receptor (CAR) use of a n
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. ICON Offers 30% Premium For PRA Health